Use of N2O in the treatment of post-ischemic brain cell deterioration
AssigneeAir Liquide Sante (International)
InventorMarc Lemaire
Life of this patent
Estimating the term…
Abstract
A medicinal composition and method to treat or minimize post-ischemic brain cell deterioration that comprises nitrous oxide or a nitrous oxide donor and xenon or a xenon donor. The medicinal composition may be administered prior to or subsequent to a stroke.
Claims14
A method for treating or minimizing, post-ischemic brain cell deterioration in humans comprising the step of administering by inhalation to a human a therapeutically-effective amount of a medicinal composition comprising 75 volume percent or less nitrous oxide and 50 volume percent or less xenon, at least part of said nitrous oxide and xenon being in gaseous form, thereby treating or minimizing post-ischemic brain cell deterioration in said human.
A method for treating or minimizing post-ischemic brain cell deterioration in humans comprising the step of administering by inhalation to a human a therapeutically-effective amount of a medicinal composition comprising a mixture of gaseous nitrous oxide and gaseous xenon, thereby treating or minimizing post-ischemic brain cell deterioration in said human, the nitrous oxide being present in an amount of 75 volume percent or less and the xenon being present at a concentration of 50 volume percent or less.
Dependencies are inferred from the claim text.